Levity Pricing: What the First-Month Discount Really Costs Over Time

Last reviewed: September 19, 2026 Last updated: September 19, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Levity offers recurring monthly billing for branded GLP-1 medications—Ozempic, Mounjaro, and Wegovy—with a first-month discount using code WELCOME. The promotional rate applies once; every subsequent month bills at the standard rate. No prepaid multi-month plans appear in Levity's documented offerings as of September 4, 2026. Over twelve months, Levity's effective monthly cost for Ozempic averages $1,194.83 (our calculation), for Mounjaro $1,294.83, and for Wegovy $1,594.83. Compounded semaglutide through PlexusDx runs $189 per month with no commitment, or $149 per month on a six-month plan—$2,268 or $1,788 annually versus Levity's $14,338 for Ozempic. The pricing gulf reflects Levity's branded-medication model; service quality, insurance coordination, and medication regulatory status differ meaningfully between the two approaches.

At-a-glance pricing

Levity pricing captured September 4, 2026; PlexusDx pricing captured July 17–23, 2026. All twelve-month totals are our calculation. PlexusDx prepaid rates shown are per-month equivalents; six-month commitment requires upfront payment of the full period.

Breaking down Levity's first-month discount

Levity applies promotional code WELCOME to reduce the first shipment by $50. For Ozempic, that means $1,149 in month one rather than the standard $1,199; for Mounjaro, $1,249 instead of $1,299; for Wegovy, $1,549 instead of $1,599. Each subsequent month bills at the standard rate—$1,199, $1,299, or $1,599 respectively—on an approximately four-week cycle, with no contract and the ability to cancel anytime.

Over twelve months, the effective monthly average (our calculation) becomes $1,194.83 for Ozempic, $1,294.83 for Mounjaro, and $1,594.83 for Wegovy. The first-month savings amount to about 4 percent of the annual cost. Levity includes consultation, care coordination, medication, and shipping in the monthly price; no separate membership fee applies.

The branded-medication premium

Levity's pricing reflects branded, FDA-approved medications manufactured by Novo Nordisk (Ozempic, Wegovy) and Eli Lilly (Mounjaro). These drugs carry full FDA review for safety, effectiveness, and quality; they are the reference standard against which other formulations are measured. Insurance may cover part or all of the cost depending on your plan and indication, though Levity's cash-pay model suggests many users pay out-of-pocket. The $1,199–$1,599 monthly rate positions Levity above nearly all compounded-medication telehealth services but within range of direct pharmacy pricing for these brands without insurance.

Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Normalized twelve-month cost comparison

To isolate the cost difference between Levity's branded model and a compounded alternative, we calculate total spend over one year assuming continuous use:

• Levity Ozempic: $1,149 (month 1 with WELCOME code) + $1,199 × 11 = $14,338 total, $1,194.83 effective monthly (our calculation).
• Levity Mounjaro: $1,249 + $1,299 × 11 = $15,538 total, $1,294.83 effective monthly (our calculation).
• Levity Wegovy: $1,549 + $1,599 × 11 = $19,138 total, $1,594.83 effective monthly (our calculation).
• PlexusDx compounded semaglutide (month-to-month): $189 × 12 = $2,268.
• PlexusDx compounded semaglutide (6-month commitment, renewed once): $149 × 12 = $1,788 (our calculation, assuming the six-month rate applies to both periods).
• PlexusDx compounded tirzepatide (month-to-month): $289 × 12 = $3,468.
• PlexusDx compounded tirzepatide (6-month commitment, renewed once): $249 × 12 = $2,988 (our calculation).

The arithmetic shows a roughly 6× to 10× difference in annual cost between Levity's branded semaglutide (Ozempic or Wegovy) and PlexusDx's compounded semaglutide, and a 5× to 6× difference for tirzepatide (Mounjaro versus compounded). That gap narrows slightly if insurance reimburses part of Levity's cost, but Levity's pricing page does not advertise insurance billing, suggesting most users pay the listed cash rate.

Where Levity's branded model may make sense

Levity offers several advantages tied to its branded-medication approach:

• FDA approval and manufacturing oversight: Ozempic, Mounjaro, and Wegovy undergo full premarket review and ongoing quality surveillance. Compounded formulations do not.
• Insurance compatibility: Some employer or public insurance plans cover branded GLP-1s for weight management or diabetes; compounded versions typically are not covered.
• Dose consistency and device engineering: Branded pens are designed for ease of use, with pre-filled cartridges and integrated safety features developed through extensive human-factors testing.
• Clinical-trial evidence base: The published literature on semaglutide and tirzepatide efficacy and safety derives almost entirely from studies of the branded drugs.

If your insurance covers Levity's medication cost or if you place high value on the FDA-approval framework, the $1,199–$1,599 monthly rate may be justifiable. Confirm insurance reimbursement directly with Levity and your plan before committing, as out-of-pocket cost at these levels becomes prohibitive for most budgets over time.

Where compounded semaglutide or tirzepatide may fit

PlexusDx's compounded-medication model serves a different use case:

• Transparent, budget-predictable pricing: $189 per month for semaglutide or $289 for tirzepatide with no commitment, dropping to $149 and $249 respectively on a six-month plan. No membership fees, no hidden charges.
• Flat rate across all doses: Your monthly cost stays constant whether you remain at a lower dose or titrate to the maximum studied level, removing a common cost uncertainty.
• No insurance required: Cash-pay simplicity; no prior authorization, no formulary negotiation, no claim denials.
• Compounding-pharmacy supply: PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician prescribes based on individual fit; the pharmacies prepare each prescription to order.

The trade-off is regulatory: compounded drugs do not carry FDA approval for safety, effectiveness, or quality. The prescribing clinician makes the suitability determination. For users paying out-of-pocket who prioritize cost predictability and are comfortable with a compounded formulation, the $2,268–$3,468 annual spend (month-to-month) or $1,788–$2,988 (six-month commitment) represents a substantial reduction versus Levity's $14,338–$19,138 branded range.

Choose Levity if…

• Your insurance plan covers branded GLP-1 medications for your indication, and Levity coordinates benefits to reduce your out-of-pocket cost meaningfully below the $1,199–$1,599 advertised rates.
• You specifically want FDA-approved Ozempic, Mounjaro, or Wegovy and are prepared to pay the branded premium in cash.
• You value the established clinical-trial evidence base and manufacturing oversight that accompanies branded drugs.
• You prefer a no-contract monthly billing model with the flexibility to cancel anytime, even at a higher recurring cost.

Confirm insurance reimbursement and final net cost before your first order. If you will pay the full advertised rate out-of-pocket, compare the twelve-month total carefully against alternatives.

Choose PlexusDx compounded semaglutide or tirzepatide if…

• You are paying out-of-pocket and want to minimize annual cost without sacrificing clinician oversight or medication access.
• You are comfortable with a compounded formulation prepared by a licensed 503A pharmacy under a provider's prescription.
• You value transparent per-month pricing that does not change with dose escalation.
• You want the option to lock in a lower rate with a three-month ($169 semaglutide, $269 tirzepatide) or six-month ($149 semaglutide, $249 tirzepatide) commitment, or retain full flexibility at the month-to-month rate.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com). Every plan includes the provider visit, prescription, medication, and shipping in one flat fee—no membership, no surprise add-ons.

Methodology and freshness

Levity pricing, plan structure, and promotional-code details were captured September 4, 2026 from the Levity website and publicly accessible marketing pages. PlexusDx pricing was captured July 17–23, 2026 from live product pages. All twelve-month totals and effective monthly averages are our calculation, derived by summing the first-month promotional rate and eleven months at the standard rate for Levity, or multiplying the stated per-month figure by twelve for PlexusDx. We assumed that PlexusDx six-month commitments renew at the same rate for the second half of the year; confirm renewal terms at intake. No prepaid multi-month plans were documented for Levity in the research; only recurring monthly billing with a one-time first-month discount appears in the evidence. Trustpilot review data for PlexusDx was captured September 9, 2026. Prices, plan availability, and promotional offers may change; confirm all figures at checkout and consult each provider's current terms before committing.

Frequently Asked Questions

Does Levity offer any plan that costs less than month-to-month billing?

No prepaid multi-month or subscription-tier discount plans appear in Levity's documented offerings as of September 4, 2026. The only cost reduction is a first-month discount with code WELCOME; every subsequent month bills at the standard rate for your chosen medication.

How much do I actually save with Levity's WELCOME code over a year?

The code reduces your first shipment, which over twelve months lowers the effective monthly average by about $4.17 (our calculation). For Ozempic that brings the average from $1,199 to roughly $1,194.83 per month—a total annual savings equal to the first-month discount.

Is PlexusDx semaglutide the same medication as Levity's Ozempic?

No. Levity dispenses Ozempic, an FDA-approved branded semaglutide injection made by Novo Nordisk. PlexusDx offers compounded semaglutide prepared by a licensed 503A pharmacy. Compounded medications are not FDA-approved and do not undergo the same premarket safety, effectiveness, or quality review as branded drugs.

Will my insurance cover Levity's branded GLP-1 medications?

Possibly, depending on your plan's formulary, your diagnosis, and prior-authorization requirements. Levity's pricing page advertises cash-pay rates; confirm directly with Levity whether they coordinate insurance benefits and what your net out-of-pocket cost will be before ordering.

Can I switch from Levity's branded medication to PlexusDx compounded semaglutide mid-treatment?

Switching between branded and compounded formulations requires a new clinical evaluation. A licensed provider will review your current dose, response, and goals to determine an appropriate starting point. Neither Levity nor PlexusDx guarantees uninterrupted transfers or identical dosing.

Sources

• PlexusDx product pages (semaglutide injection, tirzepatide injection), accessed July 17–23, 2026
• Levity website (getlevity.com), pricing and plan details, accessed September 4, 2026
• Levity promotional materials and code-redemption pages, accessed September 4, 2026
• Trustpilot profile for PlexusDx (trustpilot.com/review/plexusdx.com), rating and review-distribution data, accessed September 9, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.